Project Grant F31DA067334
Award Date 1/7/27
Completion Date 8/31/29
Dollars Obligated $100K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- The National Institute on Drug Abuse awarded The Johns Hopkins University $1.731 million on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on immune mechanisms impacting the blood-brain barrier in people who inject drugs with and without HIV. The research examines how neuroimmune-blood-brain-barrier interactions contribute to cognitive complications among people with a history of injection drug use, particularly those coinfected with HIV....
- The National Institute on Drug Abuse awarded The Johns Hopkins University $155,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2026, to develop and pilot the PROTECT-ED intervention, which addresses overdose and HIV prevention for individuals recently released from incarceration. The award funds research to refine and test an emergency department–based intervention designed to identify recently incarcerated patients and offer same-day medications for opioid...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $427,000 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, for Project Grant R21DA064465. The recipient will examine HIV, hepatitis C, and sexually transmitted infection co-infection patterns among an existing cohort of 400 rural people who inject drugs in Cabell County, West Virginia, where an ongoing HIV outbreak linked to injection drug use has persisted since 2018. The work...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $698,861 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research characterizing mitochondrial regulation of inflammaging in immune cells and neurons and its effects on cognitive function among people with HIV who use substances. The research addresses cognitive impairment affecting 30 to 60 percent of people with HIV, with persons who inject drugs representing a particularly...
- The National Institute on Drug Abuse awarded The University of Chicago $1,105,220 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Pathways to Improved Health and Housing Study, a hybrid type 2 implementation-effectiveness research study examining bundled interventions to improve HIV, substance use, and housing outcomes among individuals with criminal legal system involvement who use substances and are living with or vulnerable to HIV. The...
- The National Institute on Drug Abuse awarded Emory University $748,287 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279), to estimate population size and health indicators for people who inject drugs across U.S. cities and to develop age-stratified population estimates. The project runs through January 31, 2031, with place of performance in Atlanta, Georgia. Injection drug use carries high risk for overdose, HIV, and hepatitis C infection; however, the most...
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $233,250 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2026, for a community-based mixed-methods assessment of medetomidine and adulterated fentanyl withdrawal. The research characterizes how people who use drugs recognize and respond to medetomidine in local drug supplies, describes medetomidine withdrawal experiences, and develops transferable methods for rapid adulterant...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $686,170 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2026, to develop and evaluate the Better Together intervention, an eight-session, age-appropriate substance use prevention program for adolescents ages eleven to thirteen exposed to household challenges including parental substance use, parental incarceration, and parental mental health issues, and negative neighborhood contexts including...
- The National Institute on Drug Abuse awarded The Leland Stanford Junior University $692,570 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to model the impact of housing and drug treatment interventions for individuals with opioid use disorder. The project develops epidemiological and economic models assessing how housing provision, medication-assisted treatment, and related interventions affect health outcomes for people experiencing homelessness with opioid...